Europe More Skeptical of ADHD Diagnosis, Drugs

Europe More Skeptical of ADHD Diagnosis, Drugs Play

Oct. 11 (Bloomberg) -- Bloomberg’s Trista Kelley reports on differences between the general public in Europe and the U.S. when it comes to ADHD, and what that means for pharmaceutical companies. She speaks on Bloomberg Television’s “On The Move.” (Source: Bloomberg)

blog comments powered by Disqus